MTOR and systemic lupus erythematosus: The medical researchers have also tried to treat lupus by inhibiting type I IFNs in a variety of ways, such as glucocorticoids (Kirou and Gkrouzman, 2013), nicotinamide riboside (Wu et al., 2022) and mTOR inhibitor (Murayama et al., 2020).